Related topics:
Pfizer Inc stories:
Pfizer posts big jump in 4Q sales, profit
Feb 3rd, 2010 - Forbes
drugmaker pfizer inc., well into integrating its new wyeth unit, posted a 34 percent jump in revenue wednesday, but $3.2 billion in acquisition and restructuring charges and higher costs across the board weighed down profit. the maker of viagra
LIVE: Pfizer 4Q Earnings Conference Call >PFE
Feb 3rd, 2010 - Wall Street Journal
pfizer inc. (pfe) reported fourth-quarter earnings of 10 cents a share, or 49 cents a share excluding restructuring and acquisition charges, on revenue of $16.5 billion. analysts surveyed by thomson reuters, on average, had predicted adjusted per
Pfizer 4Q Net Doubles; Earnings View Below Street
Feb 3rd, 2010 - Wall Street Journal
(adds analyst reaction in third paragraph; adds details and background throughout; updates premarket stock price.) pfizer inc.'s (pfe) fourth-quarter earnings more than doubled from a year-earlier profit that was dampened by a legal settlement
Pfizer posts big jump in 4th-qtr sales, profit thanks to $68 billion Wyeth acquisition
Feb 3rd, 2010 - Los Angeles Times
new york (ap) - pfizer inc., fresh from its mega-acquisition of fellow drugmaker wyeth, on wednesday posted a 34 percent jump in revenue to beat wall street expectations, but its profit came up a tad short.
the maker of viagra and cholesterolPfizer trims drug pipeline after Wyeth merger
Jan 27th, 2010 - Reuters
* pfizer cuts 100 drug-development projects stocks | regulatory news | mergers & acquisitions | global markets * pulls lyrica application as add-on anxiety drug * aims to sell, outlicense many discontinued assets new york, jan 27 (reuters) - pfizer


